Phase II study of gemcitabine and docetaxel in combination for the treatment of metastatic breast cancer

RIS ID

31630

Publication Details

Goel, S., Abdi, E., Lewis, C. R., Links, M., Begbie, S., Clingan, P., Ganju, V. & Beith, J. (2009). Phase II study of gemcitabine and docetaxel in combination for the treatment of metastatic breast cancer. Asia Pacific Journal of Clinical Oncology, 5 (1), 32-38.

Please refer to publisher version or contact your library.

Share

COinS
 

Link to publisher version (DOI)

http://dx.doi.org/10.1111/j.1743-7563.2009.01189.x